A Double-blind, Placebo-controlled Study of Levetiracetam in Epilepsy Patients With Generalized Tonic-clonic Seizures Except Partial Seizures Evolving to Secondarily Generalized Seizures)
This study has been completed.
UCB Japan Co. Ltd.
Information provided by (Responsible Party):
UCB Pharma ( UCB Japan Co. Ltd. )
First received: October 22, 2010
Last updated: June 30, 2014
Last verified: June 2014
No Study Results Posted on ClinicalTrials.gov for this Study
|Study Status:||This study has been completed.|
|Study Completion Date:||May 2014|
|Primary Completion Date:||April 2014 (Final data collection date for primary outcome measure)|